Stay updated on HMPL-523 in Lymphoma Patients Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.

Latest updates to the HMPL-523 in Lymphoma Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a recording/display version change without modifying the underlying clinical trial details.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check36 days agoChange Detected- Added keyword: B-cell chronic lymphocytic leukemia to the study page. This change does not affect core content or study parameters.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded 'Results Posted' and new site details including Bergamo, Italy. Expanded Dose Escalation and Dose Expansion sections with detailed study endpoint definitions (PFS, TTR, DOR, ORR, CBR) and scheduling; removed older endpoint descriptions and some prior location text.SummaryDifference5%

Stay in the know with updates to HMPL-523 in Lymphoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.